Most recent
CLSI M52-Ed1 (R2020)
Verification of Commercial Microbial Identification and Antimicrobial Susceptibility Testing Systems, 1st Edition
This guideline includes recommendations for verification of commercial US Food and Drug Administration-cleared microbial identification and antimicrobial susceptibility testing systems by clinical laboratory professionals to fulfill regulatory or quality assurance requirements for the use of these systems for diagnostic testing.
- ADD TO ALERT |
- PDF |
Clinical And Laboratory Standards Institute [clsi]
.jpg)